Thermo Fisher ScientificvsVir Biotechnology

TMO and VIR stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$696.13

Value $259B

-0.58%
TMO's page

VIR

Vir Biotechnology, Inc.

$9.79

Value $1.7B

-1.76%
VIR's page

Thermo Fisher Scientific (TMO) has a market value of $259B and Vir Biotechnology (VIR) $1.7B. Over the last year, with dividends, TMO moved +20.7% and VIR +73.7%. Dividend yield: TMO 0.26%, VIR none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMO$259B

    VIR$1.7B

    TMO is 154 times VIR

  • Revenue, 12 months

    TMO$47.4B

    VIR$303M

    TMO is 156 times VIR

  • Net income, 12 months

    TMO$7.1B

    VIR-$185M

  • Operating margin

    TMO17.9%

    VIR-69.8%

    87.7 points apart

  • ROIC

    TMO8.2%

    VIR-19.6%

    27.8 points apart

  • P/E

    TMO36.6

    VIR–

  • Dividend yield

    TMO0.3%

    VIR0.0%

    0.3 points apart

  • 5-year return

    TMO+11.7%

    VIR-70.3%

    82.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMO+11.7%

VIR-70.3%

5010015020222023202420252026
Returns by period
PeriodTMOWith dividendsVIRWith dividends
1 year since November 14, 2025+20.7%Price +20.3%+73.7%Price +73.7%
3 years since November 16, 2023+48.8%+14.2% a yearPrice +47.3%+1.5%+0.5% a yearPrice +1.5%
5 years since November 15, 2021+11.7%+2.2% a yearPrice +10.1%-70.3%-21.5% a yearPrice -70.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMOThermo Fisher ScientificVIRVir Biotechnology

Valuation

TMOVIR
Valuation
Price$696.13$9.79
Market value$259B$1.7B
Enterprise value (EV)$294B$1.2B
P/E36.6–
P/E, 5-year median32.7–
P/B4.71.9
EV/EBIT34.7–
Free cash flow yield2.9%–

Results and growth

TMOVIR
Results and growth
Revenue, 12 months$47.4B$303M
Net income, 12 months$7.1B-$185M
Free cash flow, 12 months$7.6B-$142M
Earnings per share, 12 months$18.96-$1.25
Revenue growth, year on year3.9%-7.6%
Revenue growth a year, past+6.7%over 5 years-2.1%over 5 years
EPS growth a year, past+2.1%over 5 years–

Margins and returns on capital

TMOVIR
Margins and returns on capital
Gross margin–100.0%
Operating margin17.9%-69.8%
Net margin14.9%-61.0%
ROIC8.2%-19.6%
ROE13.4%-21.7%

Balance sheet

TMOVIR
Balance sheet
Cash$6.1B$455M
Total debt$41.4B$91M
Net debt / EBITDA3.7–
Interest cover5.5×–

Dividends and buybacks

TMOVIR
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$1.84–
Dividend growth a year, past+14.3%over 5 years–
Buyback yield1.2%–
Shareholder yield1.4%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMO or VIR

Didn't find what you were looking for?

Ask us
Which is bigger, Thermo Fisher Scientific or Vir Biotechnology?

By market value, Thermo Fisher Scientific ($259B) is about 154.3 times Vir Biotechnology ($1.7B), at today's prices.

How did TMO and VIR stock do over the last 5 years?

Since November 15, 2021, TMO's price moved +10.1% and VIR's -70.3%. With dividends: TMO +11.7% (+2.2% a year), VIR -70.3% (-21.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMO or VIR?

The dividend yield at today's price is 0.26% for Thermo Fisher Scientific and none for Vir Biotechnology. Over the last twelve months they paid $1.84 and – per share.

Which has the higher profit margins, Thermo Fisher Scientific or Vir Biotechnology?

Over the last twelve months, the net margin was 14.9% for Thermo Fisher Scientific and -61.0% for Vir Biotechnology, and the operating margin 17.9% and -69.8%. Revenue was $47.4B and $303M.

Which is the better investment, Thermo Fisher Scientific or Vir Biotechnology?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.